Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability
Open Access
- 5 October 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 34422
Abstract
Recent advances in the field of nanomedicine have demonstrated that biomimicry can further improve targeting properties of current nanotechnologies while simultaneously enable carriers with a biological identity to better interact with the biological environment. Immune cells for example employ membrane proteins to target inflamed vasculature, locally increase vascular permeability and extravasate across inflamed endothelium. Inspired by the physiology of immune cells, we recently developed a procedure to transfer leukocyte membranes onto nanoporous silicon particles (NPS), yielding Leukolike Vectors (LLV). LLV are composed of a surface coating containing multiple receptors that are critical in the cross-talk with the endothelium, mediating cellular accumulation in the tumor microenvironment while decreasing vascular barrier function. We previously demonstrated that lymphocyte function-associated antigen (LFA-1) transferred onto LLV was able to trigger the clustering of intercellular adhesion molecule 1 (ICAM-1) on endothelial cells. Herein, we provide a more comprehensive analysis of the working mechanism of LLV in vitro in activating this pathway and in vivo in enhancing vascular permeability. Our results suggest the biological activity of the leukocyte membrane can be retained upon transplant onto NPS and is critical in providing the particles with complex biological functions towards tumor vasculature.Keywords
This publication has 52 references indexed in Scilit:
- Formation of microvascular networks in vitroNature Protocols, 2013
- Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistributionJournal of Controlled Release, 2012
- Role of tumor vascular architecture in drug deliveryAdvanced Drug Delivery Reviews, 2011
- Bio-inspired, bioengineered and biomimetic drug delivery carriersNature Reviews Drug Discovery, 2011
- Frontiers in cancer nanomedicine: directing mass transport through biological barriersTrends in Biotechnology, 2010
- Tailored Porous Silicon Microparticles: Fabrication and PropertiesChemphyschem, 2010
- ICAM-1–mediated Endothelial Nitric Oxide Synthase Activation via Calcium and AMP-activated Protein Kinase Is Required for Transendothelial Lymphocyte MigrationMolecular Biology of the Cell, 2009
- Endothelial signaling in paracellular and transcellular leukocyte transmigrationFrontiers in Bioscience-Landmark, 2009
- Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted CarriersMolecular Therapy, 2008
- Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylationCell, 1991